Philips stops selling sleep ventilators in the United States. In 2022, defects in respirators sold in the markets caused huge losses to the former electronics giant, which became specialized in selling medical equipment.
The company's CEO, Roy Jacobs, said in a statement, "Resolving the consequences of the Respironics device recall for our patients and customers is a priority" The group said it set aside 363 million euros in the fourth quarter to settle the agreement, which has not yet been finalized and requires court approval.